For The Consortium

Participating Institutions

Lisa Gagalis, R.N. (right), a study coordinator in the General Clinical Research Center (GCRC) at Boston University Medical Campus, performs lung function testing on research participant Ashley Mendez, who is enrolled in a clinical trial of omalizumab, a new antibody-based treatment for asthma. This trial is being conducted as part of the Inner-City Asthma Consortium funded by NIAID of the NIH. The new BU Clinical and Translational Institute (BU-BRIDGE) will include the GCRC and fund a hospital and university-wide institute that will add multiple other programs to the portfolio of resources available for clinical researchers, including community outreach, research ethics, and bioinformatics to further translate basic science discoveries into improvements in the diagnosis and treatment of human diseases

Lisa Gagalis, R.N. (right), a study coordinator in the General Clinical Research Center (GCRC) at Boston University Medical Campus, performs lung function testing on research participant Ashley Mendez, who is enrolled in a clinical trial of omalizumab, a new antibody-based treatment for asthma. This trial is being conducted as part of the Inner-City Asthma Consortium funded by NIAID of the NIH. The new BU Clinical and Translational Institute (BU-BRIDGE) will include the GCRC and fund a hospital and university-wide institute that will add multiple other programs to the portfolio of resources available for clinical researchers, including community outreach, research ethics, and bioinformatics to further translate basic science discoveries into improvements in the diagnosis and treatment of human diseases.

Boston University Clinical and Translational Science (BU-BRIDGE) Institute

Boston, MA

Visit Site

Principal Investigator: David M. Center, M.D.

Participating Institutions and Community Partners:
Highlights:
The Boston University Clinical and Translational Science (BU-BRIDGE) Institute will integrate, connect, and expand research and programs across traditional academic departments and schools. The institute will act as a bridge between disciplines to facilitate interactions by incorporating multiple key programs that support the university-wide commitment to a home for translational research. The CTSA award will allow the Institute to build on existing strengths to create an environment linking faculty members, trainees, and university programs to speed the translation of innovations in medical science to improve maintenance of health and diagnosis and treatment of diseases and share these innovations with other University-based Clinical and Translational Science Awards. The BU-BRIDGE environment also will support the bi-directional development and translation of ideas that begin in the clinic to the BU scientific community and back to identify new ways to improve health and delivery of health care services. Moreover, the Institute will significantly enhance existing partnerships with Boston's community health centers, transforming the conduct of clinical and translational research by infusing it with community-based perspectives and needs.

Back to List